FDA.reportPublic FDA data

Application 065414

Type
ANDA
Sponsor
ACS DOBFAR

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CEFOXITINCEFOXITIN SODIUMINJECTABLE;INJECTIONEQ 1GM BASE/VIALNoYes
002CEFOXITINCEFOXITIN SODIUMINJECTABLE;INJECTIONEQ 2GM BASE/VIALNoYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
25021-109CefoxitincefoxitinSagent PharmaceuticalsANDACurrent
25021-109CefoxitincefoxitinSagent PharmaceuticalsANDACurrent
25021-109CefoxitincefoxitinSagent PharmaceuticalsANDACurrent
25021-109CefoxitincefoxitinSagent PharmaceuticalsANDACurrent
25021-110CefoxitincefoxitinSagent PharmaceuticalsANDACurrent
25021-110CefoxitincefoxitinSagent PharmaceuticalsANDACurrent
25021-110CefoxitincefoxitinSagent PharmaceuticalsANDACurrent
25021-110CefoxitincefoxitinSagent PharmaceuticalsANDACurrent
44567-245CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
44567-245CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
44567-245CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
44567-245CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
44567-245CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
44567-245CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
44567-245CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
44567-245CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
44567-246CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
44567-246CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
44567-246CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
44567-246CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
44567-246CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
44567-246CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
44567-246CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
44567-246CefoxitinCefoxitinWG Critical Care, LLCANDACurrent
63323-341CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent
63323-341CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent
63323-341CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent
63323-341CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent
63323-341CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent
63323-341CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent
63323-341CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent
63323-341CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent
63323-342CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent
63323-342CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent
63323-342CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent
63323-342CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent
63323-342CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent
63323-342CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent
63323-342CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent
63323-342CefoxitinCefoxitin SodiumFresenius Kabi USA, LLCANDACurrent